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Diastolic function predicts survival after renal
revascularization
Racheed J. Ghanami, MD,a Hamza Rana, MD,b Timothy E. Craven, MSPH,c John Hoyle, MD, MPH,d
Matthew S. Edwards, MD, MS,a and Kimberley J. Hansen, MD,a Winston-Salem, NC
Purpose: The purpose of this study was to define the relationship between left ventricular diastolic function and survival
after renal revascularization.
Methods: Seventy-six adult patients (49 women, 27 men; mean age: 63  13 years) with preoperative echocardiography
who underwent renal revascularization for atherosclerotic disease were identified. Diastolic function was estimated from
the early diastolic transmitral flow velocity (E), the atrial transmitral flow velocity (A), and the mitral annular tissue
doppler velocity (e=). Patients were divided into two groups of diastolic dysfunction as either none/mild (E/A <0.75,
E/e= <10) or moderate/severe (E/A >0.75, E/e= >10). Perioperative and follow-up mortality were determined from a
prospective vascular database and the National Death Index. Descriptive statistics were calculated and postoperative
survival was estimated by product-limit methods. Associations between preoperative factors, perioperative factors, and
follow-up survival were examined using proportional hazards regression models. A forward stepwise variable selection
procedure was used to select a “best” model to predict follow-up survival.
Results: Seventy-six patients were followed for an average of 41.9 months after renal revascularization. Within this group,
47 of 76 patients (61.8%) were identified as having moderate or severe diastolic dysfunction. Diastolic dysfunction had
no apparent association with abnormal systolic function. The mean ejection fraction for those with moderate/severe
diastolic dysfunction was 57.7%  11.5%. When comparing the moderate/severe and none/mild groupings of diastolic
dysfunction, there was a significant difference in left ventricular mass index (151.9  48.9 vs 125.3  31.7; P  .0087).
There were five deaths in the perioperative period and 20 deaths on follow-up. Among perioperative survivors,
hypertension was cured or improved in 82% of the none/mild group and 53% of the moderate/severe group (P  .012).
In multivariable analysis, none/mild diastolic dysfunction was significantly and independently associated with an
improvement in blood pressure after revascularization (odds ratio [OR], 6.2; 95% confidence interval [CI], 1.4-28.6;
P .018). Ejection fraction was not associated with survival. After forward variable selection, moderate/severe diastolic
dysfunction (hazard ratio [HR], 5.8; 95% CI 1.4-25; P  .018) was the only variable to demonstrate a significant and
independent association with follow-up survival.
Conclusion:Diastolic dysfunction, but not systolic dysfunction, was frequent in patients with renovascular disease. Blood
pressure response and follow-up survival after renal revascularization demonstrated significant and independent associ-
ations with diastolic function. Consideration of diastolic function should be included in the management of patients with
atherosclerotic renovascular disease. ( J Vasc Surg 2011;54:1720-6.)
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ePreoperative cardiac risk assessment has long been con-
sidered the effect of systolic function on perioperative mor-
bidity and survival. Conversely, preoperative evaluation has
largely ignored diastolic function. Recent reports describe
an increase in perioperative cardiac morbidity and a de-
crease in survival in patients with impaired diastolic func-
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1720ion despite normal systolic function.1-3 Given that patients
ith renovascular disease have demonstrated an increased
revalence of impaired diastolic function compared to the
eneral population,4 patients with renovascular disease un-
ergoing surgery may demonstrate a significant association
etween diastolic function and operative and postoperative
orbidity and mortality. The specific aim of this report
as to examine the association of diastolic function with
ostoperative hypertension response, postoperative renal
unction response, and follow-up survival among pa-
ients after open renal revascularization.
ETHODS
During this study period, a total of 256 renal interven-
ions were made at our institution. These included 159
pen renal artery revascularizations and 71 percutaneous
enal artery stent placements. One hundred six patients
nderwent open surgical revascularization for atheroscle-
otic renal artery disease during this period. Seventy-six
atients had cardiac stress testing and preoperative resting
chocardiography that was interpretable for diastolic func-
ion and these patients constitute this study. Twenty-two of
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cardiography alone, which could not be interpreted for
diastolic function and these patients were omitted. The
cohort of 76 adult patients (49 women, 27 men; mean age:
63  13 years) with preoperative echocardiography who
underwent open operative renal revascularization for ath-
erosclerotic disease to 114 kidneys were identified from an
institutional procedural database. Seventy-four patients un-
derwent repair for hypertension with (26 patients) or with-
out (48 patients) renal insufficiency. Two patients under-
went renal artery repair in the course of aortic aneurysm
treatment. All procedures were performed by vascular sur-
geons at Wake Forest University Baptist Medical Center
between August 2001 and October 2006. Revasculariza-
tion involved open interventions, including renal artery
endarterectomy (56 kidneys), renal artery bypass (53 kid-
neys), and nephrectomy (5 kidneys). Fifty percent of pa-
tients had bilateral renal artery repair. Renal repair was
combined with mesenteric revascularization or aortic repair
in 40 patients (53%).
Echocardiography was performed and interpreted ac-
cording to American Society of Echocardiography Recom-
mendations for Use of Echocardiography in Clinical
Trials.5 All studies were routine transthoracic resting echo-
cardiograms performed in a laboratory accredited by the
Intersocietal Commission for the Accreditation of Echocar-
diography Laboratories at Wake Forest University Baptist
Medical Center. Sonographers met or exceeded the stan-
dard for image acquisition as required by the Intersocietal
Commission for the Accreditation of Echocardiography
Laboratories and institutional study specific protocols. Af-
ter training by a dedicated research sonographer, two sep-
Table I. Descriptive characteristics classified according to
Mild/none (29 pa
Age (years)a,b 58.3 (16.
SBP (mm Hg)b 192.1 (33.
DBP (mm Hg)b 106.1 (21.
Number of medicationsb 2.4 (0.8
Serum creatinine (mg/dL)a,b 1.7 (1.1
MDRD eGFR (mL/min/1.73 m2) 46.6 (21.
Ejection fraction (%)a,b 59.2 (10.
LV mass index (g/m2) 125.3 (31.
Female gendera,b 21 (72%)
White race 26 (90%)
Dialysis preoperative 2 (7%)
History of CAD 13 (46%)
History of TIA or CVAa,b 3 (11%)
History of diabetesa,b 5 (17%)
History of CHFa,b 1 (4%)
Ejection fraction 50% 5 (17%)
Bilateral RA repaira,b 16 (55%)
CAD, Coronary artery disease; CHF, congestive heart failure; CVA, cereb
filtration rate; LV, left ventricular;MDRD,Modification of Diet in Renal Dis
aCovariate in multivariable model for survival.
bCovariate in multivariate model for blood pressure response.arate physician interpreters obtained measurements from oigitized studies in accordance with American Society of
chocardiography recommendations. Appropriate refer-
nce images were reviewed on a digital workstation. Anal-
sis of these images was performed to record data on
ntraventricular septum thickness, left ventricular (LV) pos-
erior wall thickness, end-diastolic LV internal diameter,
arly (E) and late (A) transmitral diastolic flow velocities,
ransmitral flow deceleration time (DT), and diastolic
oppler tissue velocity of the mitral annulus (e=). Systolic
unction was assessed as ejection fraction and calculated
sing the modified Simpson’s method.6 LV mass was de-
ermined using a necropsy-validated formula,7 and left
entricular hypertrophy (LVH) was considered to be pres-
nt if the LV mass/body surface area was 116 g/m2 in
en and 104 g/m2 in women. Diastolic function was
lassified as either none/mild (E/A 0.75, E/e= 10) or
oderate/severe (E/A 0.75, E/e= 10). When E/A
nd E/e= classifications differed, E/e= values were used.
Perioperative and follow-up mortality was determined
rom a prospective vascular database and the National Death
ndex. Descriptive statistics were calculated (Table I). Postop-
rative survival was estimated by product-limit methods. As-
ociations between preoperative and perioperative factors and
ollow-up survival were examined using proportional hazards
egression models. Variables considered included diastolic
ysfunction, age, preoperative creatinine, ejection frac-
ion, gender, history of transient ischemic attack or
erebrovascular accident, history of congestive heart fail-
re, history of LVH, bilateral renal artery intervention,
nd use of postoperative angiotensin receptor blocker or
ngiotensin converting enzyme inhibitor, history of dia-
etes, postoperative blood pressure response, and post-
olic function
Diastolic dysfunction
s) Moderate/severe (47 patients) P value
66.0 (9.4) .02
195.3 (34.5) .69
98.3 (19.9) .11
2.5 (1.2) .51
1.8 (1.0) .60
41.8 (19.7) .32
57.7 (11.5) .57
151.9 (49.0) .01
28 (60%) .26
46 (98%) .15
2 (4%) .63
19 (41%) .66
10 (21%) .35
12 (25%) .40
6 (13%) .24
11 (23%) .52
27 (57%) .85
ular accident; DBP, diastolic blood pressure; eGFR, estimated glomerular
A, renal artery; SBP, systolic blood pressure; TIA, transient ischemic attack.diast
tient
0)
2)
6)
)
)
5)
6)
7)
rovasc
ease;Rperative serum creatinine change. Left Ventricular Mass
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December 20111722 Ghanami et alIndex was not included in the model secondary to in-
complete data on 8 patients. Preoperative predictors of
cured or improved blood pressure response were exam-
ined using logistic regression models. For both propor-
tional hazards and logistic regression analyses, “best”
models to predict outcomes were constructed using a
forward stepwise procedure which included potential
predictors one-by-one until all those significant at the
10% alpha level were selected.
Bilateral brachial artery oscillometric measurements
were made during patient visits to the Wake Forest Univer-
sity Baptist Medical Center Vascular Surgery Clinic. Blood
pressure measurements were obtained in the sitting posi-
tion after 5 minutes of rest. Blood pressure response was
classified based on resting blood pressure and medication
requirements at the 8-week postoperative follow-up. Renal
function was estimated from serum creatinine measure-
ment at 3 weeks after surgery. This follow-up time was
selected based on previous experience that suggested early
blood pressure response (at 8 weeks) and renal function
response (at 3 weeks) demonstrated significant and inde-
pendent association with death or dialysis on long-term
follow-up.8,9 Blood pressure response was considered
“cured” in patients who had a diastolic blood pressure
(DBP) 90 mm Hg on no antihypertensive medications.
Blood pressure was considered “improved” if any of the
following criteria were satisfied: (1) blood pressure was
controlled preoperatively (ie, DBP90 mmHg) and there
was a reduction of at least two drugs postoperatively; (2)
blood pressure was not controlled preoperatively but be-
came controlled postoperatively with a 20 mm Hg de-
crease in DBP with a decrease of at least 1 medication; (3)
blood pressure was not controlled preoperatively and be-
came controlled with20mmHg decrease in DBP and no
increase in medications. Patients that did not meet criteria
for “cured” or “improved” blood pressure response were
considered “failed” blood pressure response.10
RESULTS
Seventy-six patients were followed for an average of
41.9 months (range, 0.2-77.5 months) after renal revascu-
larization. Forty-nine patients (64.5%) were women and
the mean age was 63 12.8 years. Within this group, 47 of
Table II. Blood pressure response by level of diastolic fun
Diastolic dysfunction
Number
of
patients
Preoperati
Systolic blood
pressure
Diastolic
pressur
None/mild 28 190.0 (31.8) 104.5 (2
BP: no change 5 174 (22.2) 74.2 (8
BP: cured/improved 23 193.5 (32.9) 111.1 (1
Moderate/severe 45 197.1 (33.6) 100.0 (1
BP: no change 21 191.3 (89.9) 89.9 (1
BP: cured/improved 24 202.2 (29.7) 108.8 (1
Displayed as mean (SD).76 patients (61.8%) were identified as having moderate or ievere diastolic dysfunction. Systolic function was pre-
erved. The mean systolic ejection fraction for the entire
roup was 58.3 11.1%. Diastolic function had no appar-
nt association with systolic function. The mean ejection
raction for those with moderate/severe diastolic dysfunc-
ion was 57.7 11.5% (Fig 2, online only). When compar-
ng the moderate/severe and none/mild groupings of di-
stolic dysfunction, there was a significant difference in LV
ass index (151.9 48.9 g/m2 vs 125.3 31.7 g/m2; P 
0087) as well as age (66.0 9.4 years vs 58.3 16.0 years;
 .025). There were no significant differences among the
roups in systolic blood pressure, DBP, serum creatinine,
r estimated glomerular filtration rate. Nine patients pro-
ressed to eventual dialysis dependence during the fol-
ow-up period. This included 2 patients who underwent
rimary nephrectomy and 7 patients who underwent con-
omitant aortic repair with their open renal artery proce-
ure. The preoperative mean serum creatinine was 3.1 
.0 mg/dL for patients reaching eventual dialysis depen-
ence. There were no failures of renal artery repair observed
mong this group.
There were five deaths in the hospital and within 30
ays of operation (ie, death before discharge and/or within
0 days of operation). There were 20 deaths on follow-up
mong perioperative survivors. Based on medical chart
eview, perioperative deaths were attributed to: cardiac
auses (1 patient), aspiration (1), cerebrovascular accident
1), mesenteric ischemia (1), and unknown (1). Based on
edical chart review and National Death Index data, fol-
ow-up deaths were attributed to: cardiac causes (8 pa-
ients), mesenteric ischemia (1), pneumonia (1), stroke (1),
hronic obstructive pulmonary disease exacerbation (1),
rauma (1), and unknown (7). Patency without recurrent
tenosis defined by renal duplex ultrasonography scan was
6  4% at 1 year and 92  8% at 3 years. Postoperative
lood pressure response but not renal function response
as related to diastolic function. Among perioperative sur-
ivors, hypertension was cured or improved in 82% of the
one/mild diastolic dysfunction group and 53% of the
oderate/severe group (P .012; Table II). In multivari-
ble analysis, none/mild diastolic dysfunction was signifi-
antly and independently associated with an improvement
n blood pressure (odds ratio [OR], 6.2; 95% confidence
Postoperative
Number of
medications
Systolic blood
pressure
Diastolic blood
pressure
Number of
medications
2.4 (0.8) 138.7 (20.8) 79.9 (9.1) 1.9 (0.7)
2.2 (0.8) 157.6 (32.1) 74.8 (13.6) 2.0 (0.0)
2.4 (0.8) 134.6 (15.6) 81.0 (7.8) 1.9 (0.8)
2.6 (1.2) 153.3 (29.2) 75.2 (10.8) 2.5 (1.0)
2.1 (0.9) 162.7 (34.5) 78.0 (12.8) 2.8 (1.0)
3.0 (1.3) 145.2 (21.2) 72.8 (8.3) 2.3 (1.0)ction
ve
blood
e
0.2)
.3)
5.3)
8.5)
5.3)
6.6)nterval [CI], 1.4-29.0; P  .018). In contrast to blood
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Volume 54, Number 6 Ghanami et al 1723pressure, renal function was improved in 32% of the none/
mild diastolic dysfunction group and 26% of themoderate/
severe group (P  .54).
Diastolic function but not systolic function was associ-
ated with follow-up survival. Forward stepwise selection of
variables within the multivariable proportional hazards re-
gression analysis for 71 patients demonstrated a significant
and independent association between diastolic function
and survival (hazard ratio [HR], 5.8; 95% CI, 1.4-25; P 
.018; Fig 1; Table III). No other variable (including age)
demonstrated a significant association with survival. An
additional multivariable model was created adding the co-
variate of age along with those chosen from the stepwise
selection. In this model, diastolic function remained signif-
icantly associated with long-term survival (HR, 5.1; 95%
Fig 1. Product limit estimates of long-term survival by d
in red; none/mild appears in black.
Table III. Results of forward stepwise variable selection
from multivariable proportional hazards regression model
of time to death
Analysis of maximum likelihood estimates
Covariate
Hazard
ratio
95% Hazard
ratio
confidence
limits P value
Diastolic dysfunction:
moderate/severe 5.84 1.35 25.23 .018
History of transient ischemic
attack and/or
cerebrovascular accident 2.48 0.86 7.13 .092CI, 1.2-2.3; P  .03). sISCUSSION
To our knowledge, this cohort study is the first to
emonstrate that diastolic function was significantly and
ndependently associated with blood pressure response and
ollow-up survival in patients undergoing open renal revas-
ularization. These findings affirm the increased association
f diastolic dysfunction in patients with renovascular dis-
ase and suggest an expanded role for echocardiography as
tool for risk stratification.
Diastolic dysfunction is a clinical state of impaired
entricular filling secondary to poor ventricular relaxation
nd stiffness.11 It is often classified according to four stages:
ormal, mild, moderate, and severe diastolic dysfunction.
n a normal state, the majority of ventricular filling occurs
arly in diastole as a result of negative pressure created by
entricular relaxation. On echocardiography, this is de-
icted with the early transmitral flow velocity (E). This is
upplemented late in the cardiac cycle with additional filling
ssociated with atrial contraction (A). An E/A ratio of 0.75
o 2 is seen in patients with normal diastolic function. With
ild disease there is an impairment of ventricular relaxation
ithout increase in filling pressures. This phenomenon
esults in a decrease in early filling associated with an E/A
atio less than 0.75. As diastolic relaxation decreases fur-
her, intracardiac pressures become elevated and early
ransmitral flow improves resulting in an E/A ratio that
eturns to normal. This is referred to as “pseudonormaliza-
ion” and is a sign of a moderate level of diastolic dysfunc-
ion. Observations in addition to transmitral flow velocities
ust be considered in order to differentiate pseudonormal-
zation from that of normal diastolic function. Severe dia-
lic function. Moderate/severe diastolic function appearsiastotolic dysfunction is associated with significant reductions
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annular tissue Doppler scan measurements (e=) are associ-
ated with ventricular relaxation and can be used to aid in
classification of diastolic function. Our study included both
E/A and E/e= for classification purposes because these
measures have been extensively reported by others, the
values were easily obtained by retrospective interpretation
of the echocardiography studies, and the combined use of
E/A and E/e= was not subject to pseudonormalization.
Diastolic dysfunction can be asymptomatic or manifest
as diastolic heart failure. Cross-sectional studies have shown
that up to half of patients with the clinical syndrome of
heart failure have a preserved systolic ejection fraction.15 It
is believed that these cases are comprised primarily of
patients with diastolic dysfunction.16 A report by Persson et
al17 demonstrated that 67% of hospitalized patients with
heart failure and preserved ejection fraction demonstrated
echocardiographic evidence of diastolic dysfunction of mild
to severe degrees. Moreover, these authors demonstrated
that diastolic dysfunction of a moderate to severe degree
was a significant and independent predictor of adverse
outcome. In addition, echocardiographic evidence of dia-
stolic dysfunction has been independently associated with
elevated atrial (B-type) natriuretic peptide and is a stronger
predictor than either end-diastolic volume index or ejection
fraction of atrial peptide elevation.13 Collectively, these
observations have been attributed to ventricular hypertro-
phy secondary to hypertension, ischemic ventricular
changes, and/or humoral effects. In this study, 7 patients
demonstrated a history of clinical congestive heart failure.
Three of these patients had a reduced systolic ejection
fraction and 6 patients had moderate to severe diastolic
dysfunction.
When comparing reports on diastolic function, it is
important to note the differences in the criteria for diagno-
sis and the classification of diastolic dysfunction. Some
authors advocate composite calculations of transmitral flow
estimations, tissue Doppler scan velocities, pulmonary vein
observations, and flow DTs to estimate diastolic function.
Moreover, the categorization of diastolic dysfunction varies
among reports. Different criteria have been used for diag-
nosis and different categories have been used to describe
the prevalence of diastolic dysfunction. These variations
make comparisons of study results difficult. The patients in
our study were categorized with a combination of transmi-
tral flow velocity ratios and mitral annular tissue Doppler
velocity ratios. While transmitral flow velocities can be an
effective method of classification, their interpretation can
be complicated by the effects of pseudonormalization and
low volume states. Tissue Doppler scan analysis is consid-
ered less susceptible to variations in intravascular volume.
By combining both of these measures to categorize dia-
stolic function, we believe the best estimate of ventricular
relaxation was provided.1,18-24
Our findings support prior reports that have described
a high prevalence of diastolic dysfunction in patients with
renovascular disease. In a cross-sectional study by Redfield
et al,14 echocardiography was performed in 2042 randomly zelected patients from the general population. Implement-
ng a classification scheme similar to ours, these authors
ound the prevalence of moderate or severe diastolic dys-
unction to be 7.3%. Wright et al4 found a similar preva-
ence (12%) in control patients; however, diastolic dysfunc-
ion was present in 40.5% of patients with renovascular
isease. Our study demonstrated a 61.8% prevalence of
oderate to severe diastolic dysfunction in patients under-
oing renal revascularization. This high prevalence of dia-
tolic dysfunction may be a result of a selection bias in
hich patients selected for cardiac stress testing and resting
chocardiography before surgical intervention demon-
trated more advanced disease. However, if one considered
ll unstudied patients free of diastolic dysfunction, a prev-
lence of 44% severe diastolic dysfunction would be ob-
erved for all 106 patients undergoing open operative re-
air during this reporting period.
Plausible explanations exist for the apparent association
etween renovascular disease anddiastolic function. Increased
fterload secondary to renovascular hypertension can result in
entricular hypertrophy and subsequent diastolic changes. In
itro studies have also suggested that direct humoral effects
rom the renin-angiotensin-aldosterone systemmay affect car-
iac tissue. Specifically, angiotensin II has been associated
ith increased collagen accumulation/production in cardiac
issues in animal models.25,26 In concert, these effects may
ccount for the high prevalence of diastolic dysfunction in
atients with renovascular disease.
Diastolic dysfunction has been associated with an in-
rease in morbidity and a decrease in follow-up survival
ndependent of age after other vascular procedures. Matyal
t al3 found that, among 315 vascular surgery patients,
iastolic dysfunction diagnosed by transmitral flow propa-
ation velocity was an independent predictor of postoper-
tive congestive heart failure and increased length of stay. A
ecent study by Flu et al1 evaluated preoperative echocar-
iographic data and outcome in 1005 consecutive open
nd endovascular procedures in which diastolic function
as assessed by E/A ratio andDT. Among the 649 patients
ho underwent open surgery, the authors demonstrated an
ncrease in 30-day adverse cardiac and vascular events (OR,
.8; CI, 1.1-2.9) in those with isolated LV diastolic dys-
unction. Long-term cardiac and vascular mortality was
ncreased in patients with asymptomatic and isolated dia-
tolic dysfunction (HR, 3.0; CI, 1.5-6.0).1 Collectively,
hese studies demonstrate the association of diastolic dys-
unction with perioperative and follow-up adverse out-
omes after a variety of vascular procedures.
Although diastolic dysfunction seems to be associated
ith adverse cardiac events, studies to date have shown
nconsistent response to medical management. General
ecommendations for treatment of the underlying causes of
iastolic heart failure include control of hypertension and
iabetes as well as avoidance of myocardial ischemia and
achycardia; however, there is little evidence to prove their
ffectiveness.16 Data from the Heart and Soul Study dem-
nstrated a 40% decrease in risk of heart failure hospitali-
ation in patients with diastolic dysfunction treated with
O
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sessment of Mortality and Morbidity Preserved Study
(CHARM-Preserved) examined patients with an ejection
fraction 40%. CHARM failed to demonstrate improved
survival free of clinical congestive heart failure.17 Irbesar-
tan in Heart Failure with Preserved Ejection Fraction (I-
PRESERVE) trial also failed to demonstrate improved
outcomes with the use of irbesartan in patients with dia-
stolic dysfunction.28 The value of the medical management
of diastolic dysfunction in this study is unknown but de-
serves further study.
Although we believe our findings are of potential value,
this study has several limitations. This report suffers from
the biases inherent to a retrospective report originating
from a cohort identified from an institutional procedural
database. The small size of this study limited the test of
association between diastolic function and perioperative
morbidity and mortality. Moreover, this study did not
include postoperative echocardiography to assess for
changes in heart structure on follow-up. Almost half of the
patients (48%) underwent concomitant aortic intervention
for significant disease and confounding is possible. Addi-
tionally, selection bias may have resulted from requiring
resting echocardiography. Dobutamine stress echocardiog-
raphy did not provide parameters to estimate diastolic
function. Analysis of patient characteristics among those
with resting echocardiography and those with only dobut-
amine stress echocardiography did reveal a significantly
higher preoperative systolic and DBP in those with resting
echocardiography. All other analyzed descriptive character-
istics were similar between the two groups, including age,
number of blood pressure medications, history of coronary
artery disease, history of renal insufficiency, and history of
LVH. Despite these limitations, the data and the relation-
ships demonstrated in this analysis suggest the need for
additional prospective studies to confirm the strong rela-
tionship between diastolic function, blood pressure re-
sponse, and survival among patients submitted to open
surgical repair of atherosclerotic renovascular disease.
CONCLUSIONS
Diastolic dysfunction was prevalent in patients with
atherosclerotic renovascular disease. Normal and near-
normal diastolic function demonstrated a significant and
independent association with blood pressure benefit after
open operative repair. Moreover, diastolic dysfunction
demonstrated a significant and independent relationship
with follow-up mortality. Preoperative diastolic function
should be estimated in patients with renovascular disease.
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Dr Mark G. Davies (Houston, Tex). Risk stratification of
patients and predictive models of outcomes are increasingly being
demanded by patients, physicians, quality management, hospitals,
and payers to direct care, assess quality, predict utilization, and
stratify levels of care. Left ventricular failure has been subdivided
into different forms, systolic pump failure (systolic dysfunction)
and diastolic filling failure (diastolic dysfunction). The current
report examines one component of ventricular dysfunction,
namely diastolic dysfunction. Prognosis of systolic dysfunction is
poor, with a 5-year survival rate of 40%, compared to 70% in
patients with isolated diastolic dysfunction. Renal insufficiency has
been shown to negatively influence survival in patients with dia-
stolic dysfunction. It seems that after open renal revascularization,
those with moderate to severe diastolic dysfunction have 50%
mortality, which suggests that an open intervention on the renals
has markedly worsened the natural history of the disease. The
manuscript does not correlate the preoperative cardiac variables of
congestive heart failure and flash pulmonary edema with diastolic
dysfunction, nor does it examine the correlation of diastolic dys-
function with accepted indices of perioperative cardiac risk. No
association with cardiac mortality or morbidity is brought out to
assist the reader in making a better determination of perioperative
risk. Last, the obvious question of the difference in outcomes
between open and percutaneous therapy is left unanswered, as is
the possible changes in diastolic dysfunction with time in the
survivors. I would like to ask the authors the following questions:
1. What was the correlation of the Lee Index and ASA grade with
diastolic dysfunction?
2. What was the cardiac morbidity and what was the correlation to
diastolic dysfunction?
3. Is this a general predictor of mortality and morbidity in all
vascular procedures?
4. Is there a difference in outcomes between open procedures and
endovascular procedures in patients with similar renal indica-
tions and diastolic dysfunction class?
5. Do you continue to offer open therapy to patients with signif-. In those patients that survived, were any follow-up echocar-
diographies performed and did any patients show an improve-
ment in diastolic function?
Dr Racheed J. Ghanami. Thank you, Dr Davies. Your first
uestion regarded ASA and the Lee Index. The Lee Index includes
reatinine, intent to perform high-risk procedure, history of coro-
ary artery disease, history of cerebrovascular disease, and history
f congestive heart failure. All of our patients underwent a high-
isk procedure. The remaining four factors were included in our
ultivariable model and none of them showed a significant rela-
ionship with survival. We do not know if the summation of these
actors as an index is significant. In regards to ASA, we had a small
roup of patients we felt would classify as 3s or 4s. The subjective
ature of that distinctionmade it hard to rely on any resulting data.
t was not included in the analysis. Your second question referred
o a potential difference in outcome in patients undergoing open
nd endovascular procedures and whether we thought this differ-
nce might help guide future therapy. We did not perform that
nalysis in this study, as all of the included patients were open renal
evascularizations. In your final question you inquired whether we
valuated these patients postoperatively for changes in the end
rgan (the heart). We did not perform follow-up echocardiogra-
hy on all subjects in our group of 76. Corriere et al19 have
reviously reported on 20 patients who were a subset of our group.
hat study evaluated both preoperative echocardiography and
-month post-renal intervention echocardiography. In that report,
here was a change in left ventricular mass index but there was no
ignificant change in the classification of the diastolic dysfunction.
here were 2 patients that had an unfavorable change in classifica-
ion of diastolic dysfunction; however, this was not statistically
ignificant for the cohort. To further investigate this question we
ave initiated 3-year follow-up echocardiographies of the same
roup of 20 patients. If there is a significant change in diastolic
unction with longer follow-up, it should be evident in these
atients.
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Volume 54, Number 6 Ghanami et al 1726.e1Fig 2, online only. Box and whisker plot representing the distri-
bution of ejection fraction among diastolic function groups. Top
aspect of box represents 75th percentile level for group; horizontal
line within box represents median; dot represents mean and lower
aspect of box represents the 25th percentile level. The whiskers
extend from the 25th or 75th percentile to the extreme of 1.5
interquartile ranges. The asterisk represents a measurement outside
of the 1.5 interquartile ranges.
